Company Profile (AI Text) Name: DNA Chat Corporation Canonical URL: https://wefunder.com/dnachat.precisionmedicine Updated at: 2026-06-09T05:01:14Z Tagline: DNA precision medicine in each doctor's visit Key claims: - Total raised on Wefunder: 91875 | citation: https://wefunder.com/dnachat.precisionmedicine#claim-total-raised - Total investors: 46 | citation: https://wefunder.com/dnachat.precisionmedicine#claim-total-investors Verified facts: - Total raised on Wefunder: 91875 | observed_at: 2026-06-09T05:01:14Z | expires_at: 2026-06-10T05:01:14Z - Total investors: 46 | observed_at: 2026-06-09T05:01:14Z | expires_at: 2026-06-10T05:01:14Z Computed metrics: - total_amount_raised: 91875 - total_investors: 46 - team_size: 4 - featured_investor_count: 1 - faq_count: 1 - recent_post_count: 3 Quick facts: - Pioneering the use of DNA sequencing in each doctor's visit | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-1 - 8-30x cost advantage for companies with self-insured healthcare | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-2 - Patent pending DNA Hyper-sharding technology | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-3 - Prevents 5-year diagnostic odyssey with 2 doctor's visits | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-4 - Everything is ready to sell — beta testing stage | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-5 - Insurance and Benefits Broker partner locked | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-6 - Founder with one successful exit | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-7 - $23 Bn Total Addressable Market (TAM) | citation: https://wefunder.com/dnachat.precisionmedicine#claim-fact-8 FAQ: - Q: when does your raise end? A: The offer is guaranteed through mid-December, with a potential three-week extension if needed to meet our goal. Recent posts: - Investor Update | Strong Finish – Thank You (2026-04-30T16:03:51Z) https://wefunder.com/feed/313267 - Investor Update | Oversubscribed and closing soon (2026-04-29T15:17:34Z) https://wefunder.com/feed/311578 - I ran my own genetic data through Mendly last week and found novel frameshift mutations associated with gastrointestinal stromal tumors of the colon. Even if my grandmother had gotten a colon cancer genetic panel, these wouldn't have shown up. They're not in any database, they are novel. Mendly was only able to find it because it uses symptoms + DNA sequencing + AI. (2026-01-07T15:40:52Z) https://wefunder.com/feed/240541